Carmell Therapeutics Corporation Financial Flexibility Index
Carmell Therapeutics Corporation financial flexibility index. Carmell Therapeutics Corporation (CTCX) has a Financial Flexibility Index of -0.11x as of March 2025. Free cash flow of $-752.95K (operating CF $-752.95K minus capex $0.00) represents 0% of total liabilities ($7.14 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Carmell Therapeutics Corporation (2021–2024)
Financial flexibility index of Carmell Therapeutics Corporation from 2021 to 2024. Historical Financial Flexibility Index trend for Carmell Therapeutics Corporation across 4 annual periods. Check earnings quality score of Carmell Therapeutics Corporation to evaluate the quality of earnings relative to operating cash generation.
Carmell Therapeutics Corporation Financial Flexibility Index by Year (2021–2024)
Carmell Therapeutics Corporation financial flexibility index by year from 2021 to 2024. Year-by-year free cash flow to debt coverage for Carmell Therapeutics Corporation. For the full cash flow conversion analysis, see Carmell Therapeutics Corporation (CTCX) cash conversion ratio.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.71x | $-4.39 Million | $-4.39 Million | $6.19 Million | ▼ -234.3% |
| 2023 | -0.21x | $-8.32 Million | $-8.35 Million | $39.20 Million | ▼ -145.2% |
| 2022 | -0.09x | $-3.42 Million | $-3.43 Million | $39.54 Million | ▼ -130.4% |
| 2021 | -0.04x | $-1.17 Million | $-1.18 Million | $31.13 Million | — |